191 related articles for article (PubMed ID: 23380722)
1. Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.
Konrad C; Queener SF; Wek RC; Sullivan WJ
Antimicrob Agents Chemother; 2013 Apr; 57(4):1815-22. PubMed ID: 23380722
[TBL] [Abstract][Full Text] [Related]
2. Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
Augusto L; Martynowicz J; Staschke KA; Wek RC; Sullivan WJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181373
[No Abstract] [Full Text] [Related]
3. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
Hamamura K; Minami K; Tanjung N; Wan Q; Koizumi M; Matsuura N; Na S; Yokota H
Int J Oncol; 2014 Jun; 44(6):1980-8. PubMed ID: 24691491
[TBL] [Abstract][Full Text] [Related]
4. Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis.
Benmerzouga I; Checkley LA; Ferdig MT; Arrizabalaga G; Wek RC; Sullivan WJ
Antimicrob Agents Chemother; 2015 Nov; 59(11):6939-45. PubMed ID: 26303803
[TBL] [Abstract][Full Text] [Related]
5. Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing Neuroinflammation.
Martynowicz J; Augusto L; Wek RC; Boehm SL; Sullivan WJ
mBio; 2019 Apr; 10(2):. PubMed ID: 31040237
[No Abstract] [Full Text] [Related]
6. Toxoplasma gondii Cyclic AMP-Dependent Protein Kinase Subunit 3 Is Involved in the Switch from Tachyzoite to Bradyzoite Development.
Sugi T; Ma YF; Tomita T; Murakoshi F; Eaton MS; Yakubu R; Han B; Tu V; Kato K; Kawazu S; Gupta N; Suvorova ES; White MW; Kim K; Weiss LM
mBio; 2016 May; 7(3):. PubMed ID: 27247232
[TBL] [Abstract][Full Text] [Related]
7. Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.
Hamamura K; Tanjung N; Yokota H
J Bone Miner Metab; 2013 Nov; 31(6):618-28. PubMed ID: 23536193
[TBL] [Abstract][Full Text] [Related]
8. Targeting phosphorylation of eukaryotic initiation factor-2α to treat human disease.
Fullwood MJ; Zhou W; Shenolikar S
Prog Mol Biol Transl Sci; 2012; 106():75-106. PubMed ID: 22340715
[TBL] [Abstract][Full Text] [Related]
9. Rebound of cyst number following discontinuation of guanabenz treatment for latent toxoplasmosis.
Martynowicz J; Sullivan WJ
Mol Biochem Parasitol; 2021 Sep; 245():111411. PubMed ID: 34492239
[TBL] [Abstract][Full Text] [Related]
10. Suppressed invasive and migratory behaviors of SW1353 chondrosarcoma cells through the regulation of Src, Rac1 GTPase, and MMP13.
Xu W; Wan Q; Na S; Yokota H; Yan JL; Hamamura K
Cell Signal; 2015 Dec; 27(12):2332-42. PubMed ID: 26303573
[TBL] [Abstract][Full Text] [Related]
11. TgIF2K-B Is an eIF2α Kinase in Toxoplasma gondii That Responds to Oxidative Stress and Optimizes Pathogenicity.
Augusto L; Martynowicz J; Amin PH; Carlson KR; Wek RC; Sullivan WJ
mBio; 2021 Jan; 12(1):. PubMed ID: 33500345
[No Abstract] [Full Text] [Related]
12. eIF2α-Independent Inhibition of TNF-α-Triggered NF-κB Activation by Salubrinal.
Nakajima S; Chi Y; Gao K; Kono K; Yao J
Biol Pharm Bull; 2015; 38(9):1368-74. PubMed ID: 26328492
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Guanabenz Combination Therapy against Chronic Toxoplasmosis across Multiple Mouse Strains.
Martynowicz J; Doggett JS; Sullivan WJ
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540979
[No Abstract] [Full Text] [Related]
14. Experimental Evidence Shows Salubrinal, an eIF2α Dephosphorylation Inhibitor, Reduces Xenotoxicant-Induced Cellular Damage.
Matsuoka M; Komoike Y
Int J Mol Sci; 2015 Jul; 16(7):16275-87. PubMed ID: 26193263
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of eIF2α mitigates endoplasmic reticulum stress and hepatocyte necroptosis in acute liver injury.
Tian RD; Chen YQ; He YH; Tang YJ; Chen GM; Yang FW; Li Y; Huang WG; Chen H; Liu X; Lin SD
Ann Hepatol; 2020; 19(1):79-87. PubMed ID: 31548168
[TBL] [Abstract][Full Text] [Related]
16. Salubrinal Suppresses IL-17-Induced Upregulation of MMP-13 and Extracellular Matrix Degradation Through the NF-kB Pathway in Human Nucleus Pulposus Cells.
Yao Z; Nie L; Zhao Y; Zhang Y; Liu Y; Li J; Cheng L
Inflammation; 2016 Dec; 39(6):1997-2007. PubMed ID: 27590238
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of eukaryotic initiation factor-2{alpha} promotes the extracellular survival of obligate intracellular parasite Toxoplasma gondii.
Joyce BR; Queener SF; Wek RC; Sullivan WJ
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17200-5. PubMed ID: 20855600
[TBL] [Abstract][Full Text] [Related]
18. Proteomic and transcriptomic analyses of early and late-chronic Toxoplasma gondii infection shows novel and stage specific transcripts.
Garfoot AL; Wilson GM; Coon JJ; Knoll LJ
BMC Genomics; 2019 Nov; 20(1):859. PubMed ID: 31726967
[TBL] [Abstract][Full Text] [Related]
19. Translational control in Plasmodium and toxoplasma parasites.
Zhang M; Joyce BR; Sullivan WJ; Nussenzweig V
Eukaryot Cell; 2013 Feb; 12(2):161-7. PubMed ID: 23243065
[TBL] [Abstract][Full Text] [Related]
20. Salubrinal enhances eIF2α phosphorylation and improves fertility in a mouse model of Classic Galactosemia.
Balakrishnan B; Siddiqi A; Mella J; Lupo A; Li E; Hollien J; Johnson J; Lai K
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165516. PubMed ID: 31362041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
